UK Markets closed

NVO Jan 2024 155.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.10000.0000 (0.00%)
As of 02:55PM EST. Market open.
Full screen
Previous close4.1000
Open4.1100
Bid1.6500
Ask6.5000
Strike155.00
Expiry date2024-01-19
Day's range4.1000 - 4.1000
Contract rangeN/A
Volume2
Open interest48
  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 5 December 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme

  • Zacks

    Beat the Market Like Zacks: Novo Nordisk, Axon, General Mills in Focus

    Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

  • Zacks

    Rigel (RIGL) Up on FDA Nod to Blood Cancer Drug Rezlidhia

    The FDA approves Rigel's (RIGL) Rezlidhia (olutasidenib) for treating relapsed/refractory acute myeloid leukemia with a susceptible IDH1 mutation. Stock up.